Article
The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cells
7 Oct 2022
Abstract excerpt
Immunotherapy has been established as a promising therapy for different cancer types. However, many patients experience primary or secondary resistance to treatment. Immune cells and anti-inflammatory factors are regulated by long noncoding RNAs (lncRNAs). In addition, lncRNAs have a role in immune resistance through antigen presentation loss or attenuation, PD-L1 upregulation, loss of T-cell activities, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
